Applied Sciences,
Год журнала:
2023,
Номер
13(2), С. 1152 - 1152
Опубликована: Янв. 14, 2023
Meibomitis
is
an
ocular
disease
which
leads
to
a
dysfunction
of
the
meibomian
glands.
This
ophthalmologic
may
cause
severe
pain
and
obvious
vision
loss.
The
therapeutic
protocol
used
in
treatment
this
pathology
consists
local
systemic
antibiotic
therapy.
results
obtained
using
approach
are
scarce
and,
many
cases,
result
adverse
events.
In
study,
we
propose
alternative
original
TECAR
therapy
treatments
meibomitis
disease.
endogenous
heat
produced
by
device
beneficial
effects
from
both
histological
anatomical
point
view.
Different
parameters
(TBUT,
interferometry,
tear
meniscus
height,
meibography
OCTA)
were
evaluated
before
treatments,
immediately
afterwards,
15
days
after
end
treatments.
suggest
new
possible
use
on
ophthalmological
patients,
opening
innovative
scenario
non-invasive
manner.
Oftalmología clínica y experimental.,
Год журнала:
2024,
Номер
17(S1Eng)
Опубликована: Дек. 10, 2024
The
tear
film
has
a
complex
composition
allowing
it
fulfill
multiple
functions,
such
as
optical,
lubrication,
immunological,
endocrine,
and
neurotrophic,
which
are
relevant
for
visual
health.
Alterations
in
its
components,
both
quality
quantity,
will
affect
homeostasis,
also
impacting
the
ocular
surface,
leading
to
condition
known
“dry
eye”.
Dry
eye
high
global
prevalence,
is
further
increasing
due
environmental
factors
(mainly
screen
mainly)
overall
rise
life
expectancy.
Several
products
available
treatment,
but
lubricants,
generally
referred
“artificial
tears”,
continue
be
crucial.
There
wide
variety
of
lubricant
formulations
with
different
indications,
which,
when
used
appropriately
according
type
severity
dry
eye,
allow
effective
customized
treatment.
Considering
complexity
relevance
this
issue,
Latin
American
Study
Group
on
Lubricants
Eye
(LUBOS)
was
formed.
This
work
represents
consensus
aim
creating
diagnostic
therapeutic
algorithm
focused
proper
use
providing
practical
guidance
general
ophthalmologists.
Applied Sciences,
Год журнала:
2023,
Номер
13(2), С. 1152 - 1152
Опубликована: Янв. 14, 2023
Meibomitis
is
an
ocular
disease
which
leads
to
a
dysfunction
of
the
meibomian
glands.
This
ophthalmologic
may
cause
severe
pain
and
obvious
vision
loss.
The
therapeutic
protocol
used
in
treatment
this
pathology
consists
local
systemic
antibiotic
therapy.
results
obtained
using
approach
are
scarce
and,
many
cases,
result
adverse
events.
In
study,
we
propose
alternative
original
TECAR
therapy
treatments
meibomitis
disease.
endogenous
heat
produced
by
device
beneficial
effects
from
both
histological
anatomical
point
view.
Different
parameters
(TBUT,
interferometry,
tear
meniscus
height,
meibography
OCTA)
were
evaluated
before
treatments,
immediately
afterwards,
15
days
after
end
treatments.
suggest
new
possible
use
on
ophthalmological
patients,
opening
innovative
scenario
non-invasive
manner.
